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ABSTRACT L-2-Hydroxyglutarate aciduria (L-2-HGA) is an autosomal recessive neu-
rometabolic disorder caused by a mutation in the L-2-hydroxyglutarate dehydroge-
nase (L2HGDH) gene. In this study, we generated L2hgdh knockout (KO) mice and
observed a robust increase of L-2-hydroxyglutarate (L-2-HG) levels in multiple tissues.
The highest levels of L-2-HG were observed in the brain and testis, with a corresponding
increase in histone methylation in these tissues. L2hgdh KO mice exhibit white mat-
ter abnormalities, extensive gliosis, microglia-mediated neuroinflammation, and an
expansion of oligodendrocyte progenitor cells (OPCs). Moreover, L2hgdh deficiency
leads to impaired adult hippocampal neurogenesis and late-onset neurodegenera-
tion in mouse brains. Our data provide in vivo evidence that L2hgdh mutation
leads to L-2-HG accumulation, leukoencephalopathy, and neurodegeneration in
mice, thereby offering new insights into the pathophysiology of L-2-HGA in humans.
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The rare, autosomal recessive neurometabolic disorders D-2-hydroxyglutaric aciduria(D-2-HGA) and L-2-hydroxyglutaric aciduria (L-2-HGA) are characterized by the
accumulation of D-2-hydroxyglutarate (D-2-HG) and L-2-hydroxyglutarate (L-2-HG), re-
spectively, in body fluids. Genetic characterization has shown that 50% of the D-2-HGA
population and the majority of L-2-HGA patients harbor pathogenic mutations in
D2HGDH and L2HGDH genes, respectively (1–3). The other half of D-2-HGA patients
have a gain-of-function mutation in isocitrate dehydrogenase 2 (IDH2) at the residue of
R140 (R140Q), which leads to abnormally high accumulation of D-2-HG (4). Based on
phenotypic severity in patients, D-2-HGA is classified as mild type I (D2HGDH mutation)
and severe type II (IDH2 mutation) (4, 5). Of note, 2-HG concentrations are 2- to 8-fold
higher for type II D-2-HGA than type I D-2-HGA patients (4, 6, 7), suggesting that
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endogenous D2HGDH is insufficient to metabolize the excessive D-2-HG produced
by mutated IDH2. Compared to D-2-HGA, L-2-HGA is more prevalent and severe and
mainly affects the central nervous system (CNS) starting at childhood, leading to
progressive hypotonia, tremor, epilepsy, leukoencephalopathy, mental retardation,
psychomotor regression, and low-frequency brain tumors (8–10). The neurological
symptoms in L-2-HGA patients may be due to the toxicity from L-2-HG accumulation,
although the underlying mechanisms are largely unclear.
Emerging evidence has indicated that mitochondrial dysfunction and impairment of
oxidative phosphorylation (OXPHOS) are involved in the pathology of various organic
acidemias. Recently, 2-HG has been reported to impair the activities of two enzymes in
OXPHOS, including cytochrome c oxidase and ATP synthase (11, 12), but whether the
pathogenesis of 2-HGA is associated with impairment of OXPHOS remains unknown.
Furthermore, 2-HG is now considered an oncometabolite (13–16), and numerous studies
indicate that altered epigenetic regulation is a major mechanism underlying its oncogenic
activity. The structural similarity of 2-HG to -ketoglutarate (-KG) enables it to act as
an -KG analog and inhibit the activity of multiple -KG-dependent dioxygenases,
including the JmjC domain-containing histone demethylases and the TET (ten-eleven
translocation) family of cytidine hydroxylases (13, 17–19). Supporting this notion, a
mouse Idh1-R132H knock-in study reveals increases of both DNA and histone methy-
lations (3). In vitro studies demonstrate that L-2-HG is more potent than D-2-HG in
suppressing the activity of -KG-dependent dioxygenases (13, 17).
Although it has been over 30 years since the first report of L-2-HGA, the progression
of the disease is poorly understood and little is known about its long-term impact on
neural development and neural activity (20). Recently, Rzem et al. constructed an
L2hgdh deletion mouse model and found extensive vacuolations in the central
nervous system (CNS) (21). To study the biochemical and pathophysiological con-
sequences of L-2-HG accumulation, we created L2hgdh knockout (KO) mice by
piggyBac transposon-mediated insertion mutation of the L2hgdh gene. Our data
demonstrate an age-dependent accumulation of L-2-HG in the cerebrum and altera-
tions in a subset of histone methylations in the CNS of L2hgdh KO mice. Importantly,
L2hgdh KO mice exhibit subcortical white matter abnormalities, recapitulating the
typical clinical features of L-2-HGA patients. Moreover, L2hgdh KO mice exhibit dys/
demyelination, extensive gliosis, expanded cell numbers of oligodendrocyte progenitor
cells (OPCs), and microglia-mediated neuroinflammation. Finally, L2hgdh KO mice also
show impaired adult hippocampal neurogenesis as well as age-dependent neurode-
generation.
RESULTS
L2hgdh deficiency causes 2-HG accumulation, reduced body weight, and pre-
mature death in mice. To understand the pathophysiology of L-2-HGA, we generated
an L-2-HGA mouse model in which the L2hgdh gene was disrupted by insertion of a
piggyback (PB) transposon between exon 1 and exon 2 (see Fig. S1 in the supplemental
material). Western blot analysis demonstrated expression of L2ghdh protein across diverse
mouse tissues (Fig. S2). Heterozygous insertion of the PB transposon led to reduced L2hgdh
protein expression, whereas homozygous insertion resulted in a complete loss of L2hgdh
protein in a variety of mouse tissues tested (Fig. 1A), confirming the deletion and functional
inactivation of the L2hgdh gene.
Measurement of 2-HG levels revealed that the urinary excretion of L-2-HG was
approximately 6 to 8 mmol/mmol creatinine in L2hgdh KO mice, and that the plasma
levels of L-2-HG were about 50 M (Fig. 1B and C). The L-2-HG concentrations in body
fluids of L2hgdh KO mice were much higher than those of wild-type mice and were
even comparable with those in L-2-HGA patients (2). Moreover, examination of L-2-HG
in tissues of L2hgdh KO mice demonstrated that this metabolite was most abundant in
the brain and testis, with L-2-HG concentrations of 4 mmol/kg tissue weight (Fig. 1D).
In other tissues of L2hgdh KO mice, 2-HG was accumulated to a lesser extent, ranging
from 40 mol/kg tissue weight in fat to 400 to 800 mol/kg tissue weight (Fig. 1D).
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FIG 1 Deletion of L2hgdh leads to 2-HG accumulation, reduced body weight, and premature death in mice. (A) L2hgdh
protein is diminished in L2hgdh/ mice. Western blotting of L2hgdh in tissues from cerebrum, testis, liver, kidney, and
spleen of L2hgdh wild-type and piggyBac insertion heterozygous and homozygous mice. Beta-actin was used as a
loading control (Ctr). (B and C) 2-HG is highly accumulated in urine (B) and plasma (C). 2-HG content in urine was
measured by GC-MS and normalized to creatinine. (D) 2-HG accumulation in different tissues in L2hgdh KO mice. For
each bar, tissues were collected from 3 or 4 mice at 2 to 3 months of age. (E) Temporal accumulation of 2-HG in
postnatal mouse brains. Cerebral tissue at postnatal days 1, 3, 8, 14, 18, and 180 was collected for GC-MS analysis. (F)
Age-dependent body weight loss in L2hgdh KO mice. For each time point and each genotype, n  15. (G) Reduction
of fat content in L2hgdh KO mice. Whole-body fat content was measured by a minispec (n 8 to 10 per bar). (H) L2hgdh
KO causes reduced locomotion in old mice. The open field test was applied to monitor mouse motor activity. Two age
groups, 16 to 24 weeks and 45 to 55 weeks, were selected for testing. Each dot represents the movement of an
individual mouse. (I) Premature death in L2hgdh KO mice. For wild-type and L2hgdh KO mice, n  16 and 19,
respectively. Quantifications are presented as means  SEM and were analyzed by two-tailed t test. ***, P  0.001; **,
P  0.01; *, P  0.05; n.s., not significant.
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Notably, we found an age-dependent increase of L-2-HG level in the cerebrum of
postnatal L2hgdh KO mice (Fig. 1E). The L-2-HG level in the cerebrum was about 1
mmol/kg tissue weight at neonatal day 1, gradually increased to about 4 mmol/kg
tissue weight at day 14, and thereafter was maintained at a high steady-state level (Fig.
1E). Neonatal L2hgdh KO mice exhibited no overt structural or cellular defects in the
brain (data not shown).
Strikingly, L2hgdh KO but not wild-typemice older than 6months exhibited a significant
loss in body weight, decreasing by 30% in 1-year-old L2hgdh KO mice compared to
wild-type controls (Fig. 1F). Time domain-nuclear magnetic resonance (TD-NMR) analysis
revealed that loss of body weight was largely attributed to reduced fat content in older
L2hgdh KO mice (Fig. 1G). Furthermore, the motor activity of L2hgdh KO mice and their
wild-type littermates was evaluated with the open field test (OFT), and no difference in
the moving distance was found between young L2hgdh KO mice and their wild-type
littermates aged 16 to 24 weeks (Fig. 1H). In contrast, the distance moved by older
L2hgdh KO mice was significantly decreased compared to that of their wild-type
littermates aged 45 to 55 weeks (Fig. 1H). We also found that the majority of L2hgdh KO
mice (n  18 of 19) died at the age of 48 to 72 weeks (12 to 18 months), while most
of the wild-type littermates were still alive at the same age (Fig. 1I). Collectively, these
data indicate that deletion of L2hgdh leads to reduced motor activity, reduced body
weight, and premature death in mice.
L2hgdh deficiency results in testicular atrophy and selective changes in his-
tone methylation. Our observation that L-2-HG was most abundant in the testis and
brain of L2hgdh KO mice (Fig. 1D) prompted us to examine the pathophysiological
consequences of L-2-HG accumulation in these two tissue types. We found that L2hgdh
KO mice exhibited testicular atrophy and that this phenotype was exacerbated at an
advanced age (Fig. 2A and B). Histological analysis showed that the seminiferous
tubules had normal anatomy and spermatogenesis in L2hgdh KO mice compared to the
wild-type controls (Fig. 2C). L2hgdh KO male mice were fertile but less potent than their
wild-type littermates (data not shown). Together, these data indicate that L2hgdh
deficiency and high L-2-HG accumulation affect the organ size but not the develop-
ment of the testis.
It is known that 2-HG acts as an -KG antagonist to inhibit the activity of -KG-
dependent dioxygenases, including the JmjC domain-containing histone demethylases
and the TET family of DNA cytidine hydroxylases (17, 22). We therefore performed
multiple reaction monitoring (MRM) based on liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analysis with isotopically labeled standards to quantify rela-
tive histone levels (23, 24). Our data revealed that H3K9me2 and H3K9me3 levels were
significantly increased while H3K9me0 levels were reduced in the testis of L2hgdh KO
mice (Fig. 2D). In addition, H3K27me2 levels significantly increased while H3K27me0
levels decreased moderately in the testis of L2hgdh KO mice (Fig. 2D). In contrast, other
histone methylation markers, including H3K4me1/2/3 and H3K79me1/2/3, were not
substantially changed in the testis of L2hgdh KO mice (Fig. 2D).
The effects of L2hgdh deficiency and L-2-HG accumulation on histone methylation
markers was also observed in the brain, where L-2-HG accumulation is the highest
(Fig. 1D). We found that H3K9me2 was significantly increased while the H3K9me0
level was reduced in the cerebrum of L2hgdh KO mice (Fig. 2E). As a result, the
H3K9me2/H3K9me0 ratio increased by 37% in the cerebrum of L2hgdh KO mice
compared to wild-type littermates. Moreover, H3K27me3 was significantly increased,
and the H3K27me2 level accordingly was reduced in the cerebrum of L2hgdh KO mice
(Fig. 2E). Furthermore, H3K36me2 increased significantly in the cerebrum of L2hgdh KO
mice (Fig. 2E). In contrast, other histone methylation markers were not substantially
altered in the cerebrum of L2hgdh KO mice, including H3K4me1/2/3 and H3K79me1/
2/3 (Fig. 2E). L2hgdh deficiency had no effect on histone methylation in other tissues
that showed only moderate accumulation of L-2-HG, such as the liver, kidney, and heart
(Fig. S3A to C). Collectively, these findings suggest that L2hgdh deficiency leads to
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changes in a subset of histone methylation markers in mouse testis and brain, where
L-2-HG accumulation is the highest.
Besides histone demethylases, the TET family of DNA hydroxylases is another major
pathologically relevant target of 2-HG (13, 25). TET enzymes catalyze three sequential
oxidative reactions, converting 5-methylcytosine (5mC) first to 5-hydroxymethylcytosine
(5hmC), then to 5-formylcytosine (5fC), and finally to 5-carboxylcytosine (5caC) (26–28). We
next performed LC-MS analysis to measure and quantify 5mC and its oxidative derivatives
in the cerebrum of L2hgdh KOmice and wild-type littermates. Our data demonstrated that
FIG 2 Testis atrophy and increased histone lysine methylation in L2hgdh KO mice. (A) Age-dependent testis atrophy in
wild-type (Ctr) and L2hgdh KO mice. (B) Representative testes from L2hgdh KO mice and wild-type littermates at postnatal
month 14. (C) HE staining of representative testis morphology at postnatal month 14. Scale bars at the lower and upper right
are 200 m and 50 m, respectively. (D and E) Analysis of histone methylation of the testis (D) and cerebrum (E). Histone
methylation on K4, K9, K27, K36, and K79 was determined and is presented. Quantification of histone modification was
calculated from five independent samples and is presented as means  SEM; data were analyzed by a two-tailed t test. ***,
P  0.001; **, P  0.01; *, P  0.05; n.s., not significant.
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L2hgdh deficiency and high accumulation of L-2-HG had a minor effect on the genomic
levels of 5mC/5hmC/5fC in the cerebrum of L2hgdh KO mice (Fig. S4A to C). Previously,
it was reported in an Idh1 mutant knock-in mouse model that accumulated D-2-HG in
the brain was associated with reduced hydroxylation of hypoxia-inducible transcription
factor 1 alpha (Hif-1) as well as collagen type IV, leading to endoplasmic reticulum (ER)
stress response, blood-brain barrier aberration, and hemorrhage (29). However, no sign
of hemorrhage was found in the cerebrum of L2hgdh KO mice (data not shown).
Furthermore, the levels of Hif-1 protein or eukaryotic initiation factor 2 (eIF2)
phosphorylation were not altered in the cerebrum of L2hgdh KO mice compared to
their wild-type littermates (Fig. S4D). Moreover, the blood vessel distribution of colla-
gen type IV was intense and continuous in the cerebrum of L2hgdh KO mice (Fig. S4E
and data not shown), implying that hydroxylation modification and maturation of
collagens are not disturbed by L2hgdh deficiency and L-2-HG accumulation.
L2hgdh deficiency leads to early-onset white matter abnormality. MRI (mag-
netic resonance imaging) analysis from previous reports suggest that the patho-
logical changes in L-2-HGA patients are abnormalities of the subcortical cerebral
white matter dentate nucleus, globus pallidus, putamen, and caudate nucleus (30).
Using T2-weighted MRI analysis, we found that the signal intensity of the subcortical
corpus callosum (cc) and striatum was consistently increased in L2hgdh KO mice compared
to wild-type littermates (Fig. 3A). L2hgdh KO mice therefore display white matter
abnormalities similar to those observed in L-2-HGA patients.
Changes of MRI signal intensity normally reflect alterations in chemical composition.
Therefore, we used stimulated Raman scattering (SRS) microscopy to analyze the chemical
composition of our biological samples (31, 32). While protein signal intensity did not
change in the striatum of L2hgdh KO mice, lipid signal intensity was remarkably
weakened in the white matter fiber of the striatum as well as corpus callosum in L2hgdh
KO mice compared to wild-type littermates (Fig. 3B and data not shown). Since the
white matter fiber of the striatum is mainly composed of axons and the surrounding
myelin, we hypothesized that L2hgdh deficiency leads to widespread dys/demyelina-
tion in the brain. Supporting this notion, Luxol fast blue (LFB) staining of mouse brain
cryosections revealed that the content of myelin was dramatically reduced in the
cerebrum of L2hgdh KO mice, including the cortex, corpus callosum, and striatum (Fig.
3C). Likewise, FluoroMyelin staining showed significantly reduced lipid signal in the
white matter fiber of the striatum as well as the corpus callosum in L2hgdh KO mice
(Fig. 3D and data not shown). Consistent with this finding, the total protein level of MBP
(myelin basic protein) was reduced by 60% in the cerebrum of L2hgdh KO mice
compared to wild-type littermates (Fig. 3E and F). Furthermore, transmission electron
microscopy (TEM) analysis showed reduced myelination intensity and naked axons in
the white matter fibers of the striatum in L2hgdh KO mice (Fig. 3G). Together, these
results suggest that L2hgdh deficiency leads to widespread dys/demyelination in
mouse brain.
To determine the time point when dys/demyelination initially occurred, we utilized
SRS microscopy to examine cryosections of mouse brains at different ages. We found
that the lipid signal intensity was comparable between L2hgdh KO mice and wild-type
littermates at postnatal day 9 (p9) and that the lipid signal intensity thereafter was
gradually increased in wild-type mice but much more stagnant in L2hgdh KO mice (Fig.
3H). As a result, an obvious reduction in lipid signal intensity was detected in L2hgdh
KO mice as early as postnatal day 12 (Fig. 3H).
To determine whether L-2-HG accumulation in L2hgdh KO mice impairs OPC myeli-
nation and early differentiation to oligodendrocytes, we isolated and cultured OPCs
from the cerebral tissue of KO and control mice at postnatal day 7. The isolated OPCs
were of high purity, as greater than 90% stained positive for the OPC marker NG2 (Fig.
S5A). Early differentiation of L2hgdh KO OPCs induced by thyroid hormone T3 was
unimpaired in vitro (Fig. S5B), indicating that L-2-HG affects later stages of OPC
differentiation and myelination.
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Besides dys/demyelination, an extensive spongiotic appearance was observed in
multiple brain regions in L2hgdh KO mice, such as the brainstem, the basal ganglia
(including the striatum), corpus callosum, hippocampus, inner layer of cortex, and
cerebellar nucleus (Fig. S6). The appearance of vacuoles in the brainstem of L2hgdh KO
mice was initially observed at postnatal day 8 and reached peak levels at the age of 2.5
to 3 weeks before gradually declining (Fig. S7A). This dynamic change in vacuolation
was found in most of the examined brain regions with a close initiation time between
postnatal days 8 and 11, with the exception being the dentate gyrus (DG) of the
hippocampus, where a large vacuole was first observed in 1-year-old L2hgdh KO mice
and became extremely severe thereafter (Fig. S7B).
L2hgdh deficiency leads to extensive gliosis. Approximately half of L-2-HGA
patients show macrocephaly (2). Consistent with this report, we observed that the net
brain weight was significantly increased in L2hgdh KO mice compared to wild-type
littermates above 1 year of age (Fig. 4A and B). Measurements of cerebral cortical
surface area revealed a 20 to 25% increase in L2hgdh KO mice compared to wild-type
littermates (Fig. 4D), with a 15 to 20% reduction in cerebellum surface area in L2hgdh
FIG 3 Deletion of L2hgdh leads to early-onset white matter abnormality and demyelination. (A) T2-weighted MRI.
Hyperintense signals appeared in the external capsule and striatum in a coronal brain section of L2hgdh KO mice.
The scale bar is 4 mm. (B) SRS microscopy showed a decreased lipid signal in the myelin fibers in the striatum of
L2hgdh KO mice. Lipid and protein signals are represented as green and red, respectively. Scale bars at the lower
left and right are 50 m and 10 m, respectively. (C) Luxol fast blue imaging of a whole coronal section showed
reduced signal intensity in L2hgdh KO mice. The scale bar is 2 mm. (D) L2hgdh KO mice showed decreased
FluoroMyelin staining in the myelin fibers of the striatum. Scale bars at the lower and upper right are 50 m and
25 m, respectively. (E and F) Western blotting of cerebrum samples for MBP (E) and quantification of results (F).
***, P  0.0001. pb/pb, homozygous piggyback transposon insertion into the L2hgdh gene, equal to KO. (G)
Transmission electron micrographs (TEM) of the myelin fibers in the striatum showed reduced myelination, naked
axons, and vacuolation in L2hgdh KO mice. Mice aged 2 to 6 months were selected, and a representative image
at 2 months is shown. Scale bars at the lower and upper right are 4 m and 2 m. (H) SRS microscopy for the
myelin fibers of the striatum at postnatal ages p9, p12, p14, p21, p28, p60, p180, p360, and p480. The scale bar is
50 m.
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FIG 4 Deletion of L2hgdh increases glial cells and brain mass. (A) L2hgdh KO mice show increased brain weight at 14 months but not
4 months compared to their wild-type controls. Note that L2hgdh KO mice express RFP and have a red color due to the inserted
transposon construct. For each group, n  3. (B to E) Whole-mount images (B) and size quantification for OB (C), cerebrum (D), and
cerebellum (E) of 14-month-old L2hgdh KO mice compared to their wild-type controls. For each group, n  3. The scale bars are 1 cm.
(F to H) Age-dependent increase in nuclear number in L2hgdh KO mice and quantification in the VI layer of primary somatosensory
cortex (G) and the external capsule (H). DAPI was used for nuclear staining. ec, external capsule; CPu, striatum; ctx, cortex. The scale
(Continued on next page)
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KO mice (Fig. 4E). In contrast, the surface area of olfactory bulbs (OB) was unchanged
in L2hgdh KO mice compared to the wild-type controls (Fig. 4C). Notably, 4=,6-
diamidino-2-phenylindole (DAPI) staining for DNA revealed that the number of nuclei
increased in the cerebrum of L2hgdh KO mice in an age-dependent manner (Fig. 4F). To
confirm this observation, we quantified the number of nuclei in layer IV of the primary
somatosensory cortex and beneath the external corpus in the brains of L2hgdh KO and
wild-type littermates at different ages. There were no differences in the number of
nuclei in the cortex or external corpus regions between L2hgdh KO mice and wild-type
littermates at postnatal day 20 or 60 (Fig. 4G and H). Strikingly, the number of nuclei in
the cortex and external corpus increased significantly (by 35 to 45% and 3.5- to 4.5-fold,
respectively) in L2hgdh KO mice compared to wild-type littermates at postnatal day
240. Actually, a 2- to 2.5-fold increase in nuclear number was observed even earlier in
the external corpus of L2hgdh KO mice at postnatal day 120 (Fig. 4H). Together, these
findings suggest that L2hgdh deficiency leads to an age-dependent increase in cell
number in the cerebrum, which may contribute at least in part to macrocephaly.
The CNS is composed of diverse cell types, including neurons, astrocytes, oligoden-
drocytes and their progenitor cells (OPCs), and microglia. To identify the cell types(s)
responsible for increased nuclear number in the cerebrum of L2hgdh KO mice, coronal
sections of mouse brains were immunostained with different cell-type-specific markers.
Neurons are the major cell type in the CNS and account for about two-thirds of the total
cell population in the adult mouse brain. We found that NeuN cells were barely detectable
in the external corpus of L2hgdh KO mice or wild-type littermates (Fig. 4I). No differences
in NeuN cell number were observed in the cortex between L2hgdh KOmice and wild-type
littermates (Fig. 4L), suggesting that neurogenesis in the cerebrum, which mostly occurs in
the embryonic stage, is not disturbed. In contrast, Gfap (an astrocyte activation marker)
dramatically increased in several regions of the cerebrum in L2hgdh KO mice older than 4
weeks, including the inner layer cortex, white matter, and striatum (Fig. 4J, M, and data not
shown). Consistent with this, quantitative reverse transcription-PCR (qRT-PCR) analysis
showed that Gfap mRNA levels increased 2.5- to 3-fold in the cerebrum of L2hgdh
KO mice compared to wild-type littermates, while that of Aldh1l1, another astrocyte
marker, was unchanged (Fig. S8), suggesting that L2hgdh deficiency and L-2-HG
accumulation lead to activation but not increased proliferation of astrocytes in mouse
brain. Astrocyte activation is often concomitant with the activation of microglia, which
are considered resident macrophage cells and act as the first line of innate immune
defense in the CNS. Indeed, we found that Iba1 cells increased by 3-fold in the
external corpus of L2hgdh KO mice at postnatal day 120 (Fig. 4K and N). In addition, the
population of Olig2-positive cells (an oligodendrocyte lineage marker) increased by
2-fold and accounted for 78% of all cells in L2hgdh KO mice at p120 (Fig. 4O and R).
These data indicate that the expansion of oligodendrocyte lineage cells is a major
contributor to increased nuclear number in L2hgdh KO mice. The oligodendrocyte
lineage is comprised of OPCs. We found that the levels of Ng2-positive oligodendro-
cytes and CC1-positive OPCs were increased by 2- to 2.5-fold and 1.5- to 2-fold,
respectively, in the external corpus of L2hgdh KO mice (Fig. 4P, Q, S, and T).
OPCs have been proposed to be the origin of gliomas (33, 34). The observed OPC
expansion in the cerebrum of adult L2hgdh KO mice prompted us to investigate the
oncogenic effect of L2hgdh deficiency and L-2-HG accumulation in the CNS. IDH1
mutant gliomas, which exhibit high levels of D-2-HG, often contain mutations in p53
(35, 36). We therefore crossed L2hgdh KO mice with p53 KO mice and found that L2hgdh
FIG 4 Legend (Continued)
bar is 100 m. (I to N) Increase in nuclear number was accompanied by reactive astrocytes and an increase in microglia but not
neurons. Reactive astrocytes are represented by upregulation of Gfap in L2hgdh KO mice (J), and the quantification is shown (M). NeuN
(I and L) and Iba1 (K and N) are representative markers for microglia and neurons, respectively. The scale bar for panels I to K is 200
m. (O to Q) Immunostaining with oligodendrocyte lineage cell marker Olig2 (O), OPC cell marker NG2 (P), and mature oligoden-
drocyte marker cc-1 (Q), which is quantified in panels R to T. The scale bar for panels I to K is 200 m. Quantifications are presented
as means  SEM and were analyzed by two-tailed t test. ***, P  0.001; **, P  0.01; *, P  0.05; n.s., not significant.
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and p53 double KO mice developed tumor types similar to those of p53 single KO mice,
most of which were lymphoma and peripheral tumors but not brain tumors (data not
shown). Notably, deletion of both L2hgdh and p53 genes did not significantly change
tumor-free survival in mice compared to the single p53 deletion controls (Fig. S9). A
likely explanation is that the p53 deletion produces a very strong tumor phenotype,
which may mask the effect of L2hgdh deficiency on tumorigenesis. Together, our data
suggest that L2hgdh deficiency and L-2-HG accumulation lead to an increased glial
population and a neoplastic state via the expansion of OPC; however, deletion of
L2hgdh does not induce an overtly malignant phenotype in mouse brains either alone
or in combination with whole-body p53 deletion.
L2hgdh deficiency results in reactive gliosis and neuroinflammation. As shown
earlier in this study, a subset of histones showed increased methylation in the CNS of
L2hgdh KO mice (Fig. 2E). Histone methylation not only affects chromatin status and
transcription factor recruitment to regulate gene expression (37) but also has been
linked to a number of neurological and psychiatric disorders (38). This prompted us to
perform RNA-sequencing experiments in hippocampal tissue of mice at the age of
postnatal day 60, when glial cell numbers have not yet increased. Surprisingly, there
were only selective groups of genes whose transcriptional expression was different in
the hippocampus of L2hgdh KO mice compared to wild-type littermates (Fig. 5A and B).
For instance, the gene ontology (GO) item “oxidation reduction” is the top dysregulated
pathway in the L2hgdh KO mice compared to wild-type littermates (Fig. 5C). In
accordance with this, we found that the level of glutathione (GSH) was significantly
reduced by 30% in the cerebrum of L2hgdh KO mice (Fig. 5D). In agreement with our
histological findings (Fig. 3 and 4), we detected significant dysregulation of GO items
involved in myelination, axon ensheathment, and cell proliferation in L2hgdh KO mice
(Fig. 5C). In addition, genes involved in “immune response” and “chemotaxis” were also
dysregulated (Fig. 5C). To verify the RNA-sequencing data, we performed qRT-PCR
analysis and found that multiple genes involved in chemotaxis and immune response
were indeed upregulated in the cerebrum of L2hgdh KO mice, including Clec7a, Itgax,
Cybb, Tnf, and Ccl family genes Ccl3/4/6 but not Ccl2/5 (Fig. 5E). When mouse brain
tissues were immunostained with Cd3 and Mpo (lymphocyte and neutrophil markers,
respectively), we found that neither Cd3 nor Mpo cells could be detected in the
cerebrum of L2hgdh KO mice or wild-type littermates (Fig. S10). This indicated that the
observed immune response triggered by chemotaxis in the cerebrum of L2hgdh KO
mice is not caused by peripheral lymphocyte or neutrophil infiltration into the CNS. It
should be noted that genes involved in the pathways of chemotaxis and immune
response are predominantly expressed in microglia in the CNS (Fig. S11). Immunoflu-
orescence staining demonstrated that the signal intensity of Cd68 was significantly
upregulated in the cerebrum of L2hgdh KO mice at postnatal day 60 and strongly
overlapped with microglia-specific marker Iba1 (Fig. 5F), indicating that the elevated
immune response is mediated by microglia. Our data therefore suggest that L2hgdh
deficiency leads to microglia activation prior to cell number proliferation in the adult
mouse brain.
L2hgdh deficiency results in impaired adult hippocampal neurogenesis and
late-onset neurodegeneration. We next investigated the impact of L2hgdh deletion
and 2-HG accumulation on neurons, the major cell type in the CNS. Continuous
neurogenesis throughout life occurs primarily in the subventricular zone of the lateral
ventricles (SVZ) as well as the subgranular zone (SGZ) of the DG in the hippocampus.
Notably, we found that the number of cells which were positive for nestin, a specific
marker for neural progenitor cells (NPCs), decreased by 80% in the SGZ of 8-week-old
L2hgdh KO mice compared to that in wild-type controls (Fig. 6A and B), suggesting that
L2hgdh is important for maintaining the NPC pool in the hippocampal SGZ of the adult
mouse brain. In addition, we also used specific cell lineage markers to test the effect of
L2hgdh KO on the population of nonradial progenitor cells and newborn neurons.
Immunofluorescence staining illustrated that the number of Tbr2-positive nonradial
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FIG 5 Deletion of L2hgdh results in disturbed redox status and neuroinflammation. (A) Gene expression
profiling and clustering analysis of the hippocampus of L2hgdh KO mice and their wild-type controls. (B)
MA plot of differential gene expression in the brains of L2hgdh KO and wild-type mice. The horizontal axis
represents gene expression levels (FPKM), while the vertical axis represents relative fold changes in gene
expression between L2hgdh KO and wild-type mice. Each dot represents one gene, and red dots indicate
genes with differential expression using a cutoff (q value) of 0.1 (Benjamini-Hochberg method or false
discovery rate). (C) Gene ontology (GO) analysis of differentially expressed genes. (D) L2hgdh KO reduces
GSH levels in the cerebrum. Whole-cerebrum tissues of adult L2hgdh KO and wild-type mice were used
for LC-MS/MS to measure GSH and GSSG levels. Three mice were used for each group. (E) qRT-PCR
(Continued on next page)
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progenitor cells decreased by 70% in the SGZ of 8-week-old L2hgdh KO mice (Fig. 6C
and D). Moreover, Dcx-positive newborn neurons were reduced by 60 to 70% in the
same brain region in L2hgdh KO mice (Fig. 6E and F and Fig. S12). Together, these
results provide in vivo evidence that adult hippocampal neurogenesis is impaired in
L2hgdh KO mice.
Furthermore, we analyzed NPCs isolated from neonatal mouse hippocampus and
found that L2hgdh-deficient NPCs showed lower proliferation capacity than the wild-
type controls (Fig. 6G). To determine the self-renewal capacity of these NPCs, primary
neurospheres were individually dissociated into single cells and replated at clonal
density for three additional passages. This replating assay revealed that L2hgdh-
deficient NPCs also exhibited lower capacity for self-renewal (Fig. 6G). However, we
found that the differentiation potential of NPCs was not affected by L2hgdh deletion
(Fig. 6H to J). Upon differentiation in vitro, the neurospheres from L2hgdh KO mice were
tripotent, with comparable abilities to generate neurons, astrocytes, and oligodendro-
cytes as evidenced by immunostaining of Tuj1, Gfap, and O4 markers, respectively
(Fig. 6H to J). Thus, these data provide evidence that L2hgdh deficiency reduces the
self-renewal capability of NPCs, thereby contributing to the impaired adult hippocam-
pal neurogenesis in L2hgdh KO mice.
Reactive gliosis and neuroinflammation could be strong driving forces to facilitate
neurodegeneration (39, 40). To examine neurodegeneration in L2hgdh KO mice, we
performed Fluoro Jade-C (FJC) staining, which is widely used to label degenerating
neurons (41). The number of FJC-positive cells increased remarkably in the cerebrum,
especially the basal ganglia regions, including the globus pallidus and striatum, of
14-month-old L2hgdh KO mice compared to the wild-type controls (Fig. 6K and O and
data not shown). In accordance with this, terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling (TUNEL)-positive and cleaved caspase 3-positive signals were
much stronger in the cerebrum of 14-month-old L2hgdh KO mice than in wild-type
littermates (Fig. 6L, M, P, and Q), indicating that apoptosis is highly elevated in L2hgdh-
deficient mouse brains.
DISCUSSION
In this study, we provide in vivo evidence that mutation of the detoxification enzyme
L2hgdh, likely due to L-2-HG accumulation, causes abnormal myelination, disturbed glia/
adult neural stem cell homeostasis, and increased cell death in the central nervous system.
The major findings of this study, as summarized in Fig. 7, are as follows. Deletion of the
L2hgdh gene leads to a time-dependent accumulation of the enzyme’s substrate,
L-2-HG, from 30 M in control mouse tissues up to 4,000 M in brain and testis,
whereas most other tissues accumulate L-2-HG to 500 M. The earliest lesions in the
central nervous system, which begin at postnatal week 2, include dysmyelination and
vacuolation and are mainly but not exclusively myelin-rich regions of the corpus
callosum (cc) and striatum fibers. In the dentate gyrus (DG), vacuoles are initially formed
at 1 year of age but are exacerbated with age. The temporal heterogeneity of vacuo-
lation suggests that there is more than one mechanism contributing to vacuolation in
different brain regions. Gliosis represented by neuroinflammation of microglia and
astrocyte activation starts as early as week 3 to 4. The neuroinflammation of microglia
is strongly associated with the vacuolation (except in the DG), as both phenotypes
decrease with time. L2hgdh deletion also increases the adult glial cell population,
including oligodendrocytes, OPCs, and microglia. The increased number of oligoden-
drocytes, possibly from increased proliferation and differentiation of progenitor OPCs,
FIG 5 Legend (Continued)
verification of differentially expressed genes categorized as the GO items “chemotaxis” and “immune
response.” (F) Cd68 signal is upregulated in 2-month-old L2hgdh KO mice. Coimmunofluorescence of
Cd68 and microglial marker Iba1 shows highly overlapped staining. Representative images were taken in
the striatum. The scale bar is 30 m. Quantifications are presented as means  SEM and were analyzed
by two-tailed t test. ***, P  0.001; **, P  0.01; *, P  0.05; n.s., not significant.
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FIG 6 Deletion of L2hgdh results in impaired neurogenesis, neurodegeneration, and cell death. (A) Nestin staining in neural progenitor
cells in the adult SGZ. Shown are coronal images of the SGZ in 2-month-old L2hgdh KO and wild-type mice. Their density is quantified
in panel B. (C and D) Reduction of Tbr2 intermediate progenitors in 2-month-old L2hgdh KO mouse brains compared to controls. (E
and F) Reduction of newborn neurons represented by Dcx cells in 2-month-old L2hgdh KO compared to control mouse brains. The
scale bars for panels A, C, and E at the lower right are 100 m, and the upper right insets are enlarged images with a scale bar of 50
m. (G) L2hgdh KO reduces the self-renewal of neural progenitor cells in vitro. Neural progenitor cells were isolated from the
hippocampus and cultured for four generations, with an initial seeding density of 50,000 cells/well. (H to J) The tripotent differentiation
capacity of L2hgdh KO neural progenitor cells. Neural progenitor cells isolated from the hippocampus of L2hgdh KO and wild-type mice
(Continued on next page)
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might be a compensatory effect in response to reduced myelination. L-2-HG accumu-
lation may compromise the maintenance of the neural progenitor pool, leading to
reduced neurogenesis without affecting the tripotent differentiation potential of NPCs
in vitro. The long-term burden of high L-2-HG levels could further induce apoptosis and
neurodegeneration, eventually leading to decreased motor activity, reduced body
weight, and death.
Our current study is in line with previous work conducted by Rzem et al., demon-
strating that L-2-HG accumulates most significantly in the brain and testis of L2hgdh KO
mice (21). We further show that high L-2-HG burden led to epigenetic disruption and
progressive atrophy of the testis. In previous studies, L2hgdh KO mice exhibit increased
distance of movement in OFT; however, this was not observed in our current study.
This may be due to age differences of mice used for comparison, as we also observed
increased motor activity in younger mice (data not shown). We speculate that the
long-term burden of high L-2-HG could severely compromise motor activity, as most
L2hgdh KO mice older than 8 months completely lost movement under routine feeding
conditions. Moreover, this is in line with clinical reports that L-2-HGA patients exhibit
delayed motor development, frequently accompanied by loss of milestones like unas-
sisted walking (2).
Both dys/demyelination and vacuolation occur during the second week after birth
in the L2hgdh KO mice. This time point closely correlates with the peak accumulation
of L-2-HG. Considering that most peripheral tissues contain less than 1 mM L2-HG and
are quite normal in L2hgdh KO mice, intracellular L-2-HG levels may need to reach a
higher level (i.e., 1 mM) to cause pathological changes. Postnatal week 2 is crucial for
CNS pathology in L2hgdh KO mice, as it is a critical time point for OPC differentiation,
oligodendrocyte maturation, and axon myelination in the mouse brain (42, 43). Myeli-
FIG 6 Legend (Continued)
were induced to differentiate into neurons, astrocytes, and oligodendrocytes in vitro. Scale bars for panels H to J are 100 m. (K to
Q) Neurodegeneration caused by L2hgdh KO in the CNS. Serial coronal sections from 14-month-old L2hgdh KO and wild-type mice
were used for Fluoro Jade-C staining (K), cleaved caspase 3 (L), and TUNEL staining (M). Representative images of the globus pallidus
are shown. The scale bar is 100 m. (O to Q) Respective quantifications of data from panels K to M. Quantifications are presented as
means  SEM and were analyzed by a two-tailed t test. ***, P  0.001; **, P  0.01; *, P  0.05; n.s., not significant.
FIG 7 Schematic illustration of disease onset in L2ghdh KO mice. The red arrows indicate activation or increase, while blue
arrows indicate inactivation or reduction.
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nation is relatively normal at postnatal day 9 but the deficiency occurs around postnatal
day 12, suggesting that early development, differentiation, and maturation of oligo-
dendrocytes are normal. It is possible that L-2-HG affects mostly the later stages of
oligodendrocyte maturation and myelination.
Vacuolation of the CNS is a common feature in mice with high levels of either L-2-HG
or D-2-HG, as this phenotype is also observed in mutant IDH2-R140Q or IDH2-R172K
knock-in mice, which accumulate D-2-HG (44). We speculate that neuroinflammation and
microglia activation are a host defense reaction against vacuolation for the following
reasons: (i) the vacuolation appears earlier and is followed by neuroinflammation and
microglia activation; (ii) the activated microglia are recruited and highly proliferative
around the vacuolation region in corpus callosum (cc) and myelin fiber of striatum
(CPu); (iii) when mice are older than 1 year, the vacuolation phenotype becomes less
severe. Concomitantly, the neuroinflammation and microglia activation are diminished.
The alpha-KG-dependent dioxygenase family consists of more than 60 members,
and they catalyze hydroxylation reactions on diverse substrates, including histone and
DNA demethylation (18). Both D-2-HG and L-2-HG are structurally similar to alpha-KG
and have been shown to inhibit dioxygenases (13, 17, 45). Although L-2-HG is more
potent than D-2-HG in inhibiting these enzymes, not every alpha-KG-dependent dioxy-
genase exhibits the same sensitivity to D-2-HG or L-2-HG. In fact, L-2-HG inhibits
different dioxygenases with a wide range of potencies in vitro (17). The enzymes with
the lowest 50% inhibitory concentrations (IC50s) were histone demethylases KDM4A/
JMJD2A (IC50 of 26  3 M) for H3K9 and H3K36, KDM4C/JMJD2C (IC50 of 97  24 M)
for H3K9 and H3K36, and KDM2A/FBXL11 (IC50 of 48  15 M) for H3K36. In contrast,
the enzyme PHD2, which is responsible for Hif-1 hydroxylation and ubiquitination-
mediated degradation, has a relatively high IC50 of 419 150 M (17). As a competitive
inhibitor, the IC50 of L-2-HG depends on the concentration of alpha-KG and other
cosubstrates used in the enzymatic assays. Therefore, we take caution in comparing
the in vitro IC50 and in vivo effectiveness of L-2-HG in dioxygenase inhibition. In the
L2hgdh KO mice, neither ER stress nor a global increase of Hif-1 was detected. These
phenotypes are different from those of the IDH1-R132H knock-in mice (29). Interest-
ingly, a significant increase in global methylation of H3K9, H3K27, and H3K36, but not
H3K4 or H3K79, was found in the brain and testis, two regions with the highest L-2-HG
accumulation in L2hgdh KO mice. We speculate that the L-2-HG accumulated in the
brain and testis of L2hgdh KO mice selectively inhibits some members of the JmjC
domain-containing histone demethylases.
Both L-2-HG and D-2-HG are normal metabolic by-products (46). Their intracellular
levels in most normal cells and tissues are maintained at low levels through the actions
of L2HGDH and D2HGDH (5, 47, 48). Currently, few physiological roles have been
associated with either enantiomer of 2-HG. High levels of 2-HG have been implicated
in pathogenesis of acidurias, as found in the patients with mutations in L2HGDH or
D2HGDH. Moreover, D-2-HG acts as an oncometabolite in various human cancers
harboring mutations in IDH1 or IDH2. Approximately 80% of secondary glioblastomas,
20% of AML, 50% of chondrosarcomas, and 10 to 20% of cholangiocarcinomas accu-
mulate high levels of D-2-HG due to IDH1 or IDH2 mutations (49–54). Furthermore,
L-2-HG is elevated in clear cell renal cell carcinoma (ccRCC) due to reduced expression
of the L2HGDH gene. In line with the oncogenic function of 2HG, we found a massive
expansion of OPCs in L2hgdh KO mice, suggesting a neoplastic effect of L-2-HG.
However, no brain malignancy was found in the L2hgdh KO mice, indicating that
accumulation of L-2-HG alone is insufficient to induce glioma in mice.
L2hgdh KO mice display deficiencies in adult neurogenesis; a similar phenotype has
also been observed in Tet1 deletion mice (55). Tet1 is highly expressed in the CNS
and plays an important role in DNA demethylation (55, 56). In Tet1-deficient mice,
hypermethylation and reduced expression are observed in genes involved in neuronal
progenitor proliferation (55). Similar to the Tet1 KO mice, neural progenitor cells (NPCs)
isolated from the hippocampus of L2hgdh KO mice showed reduced capacity for
self-renewal; however, this reduction was modest and may not explain the dramatic
L2hgdh Deficiency Causes Brain Defects Molecular and Cellular Biology
April 2017 Volume 37 Issue 8 e00492-16 mcb.asm.org 15
reduction in neurogenesis in vivo. Additional causes, such as increased apoptosis, were
observed in the L2hgdh KO brain and may contribute to the neurogenesis defects in the
L2hgdhd mice. The L2hgdh KO mice presented in this report provide a valuable model
for studying the role of L-2HG in the pathophysiology of human diseases.
MATERIALS AND METHODS
Mice and ethics statement. FVB background L2hgdh knockout (KO) mice (L2hgdh/) were gener-
ated by the Institute of Developmental Biology and Molecular Medicine (IDM) at Fudan University using
the piggyBac transposon insertion method. Briefly, a modified piggyBac transposon harboring the red
fluorescent protein (RFP) gene was inserted between exon 1 and exon 2 of the L2hgdh allele. The
genomic insertion site is chr12:70798148, and the corresponding insertion DNA sequence is 5=-AATT
GTGATTCAAAAATAACATTTCCAGGAATGGAAGCTATACTATGTTATAAAATGCAAAAGCAAGATAGCAAGA
TACCTCTGTAACTTGGTGCCGTTGGCGTTTGTATTGGATAGTTGTTTGCTGTGAGGCC-3=. The underlined se-
quence, AATT, is the insertion site. Knockout efficiency was confirmed by genomic PCR, protein Western
blotting, and accumulation of the L2HGDH substrate L-2-hydroxyglutarate. Whole-body p53 KO mice
(B6.129-Trp53tm1Srcmo) were purchased from Shanghai Biomodel Organism and verified by genomic PCR.
Trp53/tm1Srcmo mice were crossed with L2hgdh/ mice to produce double heterozygous mice (F1). The
F1 mice were then intercrossed to produce double-gene-knockout mice and the corresponding control
mice with Trp53 knockout and wild-type L2hgdh.
For all of the following experiments, littermate mice were used unless stated otherwise. Mice were
bred under standard husbandry conditions at the Fudan University mouse facility on a 12-h light/dark
cycle, and all experiments were performed in accordance with the Animal Care and Use Committee at
Fudan University.
Neural stem cell assay. Hippocampus cells were dissected from neonatal mouse brain, dissociated
using a cell dissociation reagent (A1110501; Thermo), and filtered through a 40-m cell filter (Falcon).
Cells were quantified by hemocytometer and plated on 6-well ultralow attachment plates (CLS3471-
24EA; Corning) at a density of 50,000 cells/well to form neurospheres. The cell growth medium consisted
of Dulbecco’s modified Eagle’s medium nutrient mixture F-12 (10565-018; Thermo) supplemented with
N-2 supplement (17502-048; Thermo), B27 supplement minus vitamin A (12587-010; Thermo), epidermal
growth factor (EGF; PHG0311; Thermo), fibroblast growth factor (FGF)-basic (PHG0026; Thermo), and
penicillin-streptomycin (15070-063; Thermo). Cultured neurospheres were cultured for 7 days before
dissociation for cell counting. The tissue/neurosphere dissociation was continued for 4 passages and
labeled as primary passage (1st), secondary passage (2nd), 3rd passage, and 4th passage.
The in vitro differentiation of neural stem cells was performed with NeuroCult differentiation medium
(05704; Stem Cell). Briefly, neurospheres from secondary passage at day 3 to 5 were dissociated to
single cells and plated onto 8-well glass chambers (154941; Nunc) in differentiation medium. After a
7-day culture, cells were fixed and used for immunostaining.
TEM analysis. For TEM, mice were perfused sequentially with phosphate-buffered saline (PBS) and
prewarmed 2% glutaraldehyde–2% paraformaldehyde (PFA) in PBS. After perfusion, tissues were fixed
overnight and coronally sectioned at 100-m thickness by a vibratome (VT1200S; Leica). Tissues were
then fixed in OsO4 for 1 h and embedded in epoxy resin. Ultrathin sections were cut with a diamond knife
to 75 nm (EM UC6; Leica) and visualized using TEM (JEM-1230; JEOL).
SRS analysis. Details for the SRS microscope setup were described previously (31, 32).
OFT. The OFT comprehensively assessed behavioral and locomotor activity levels of rodents, which
can be correlated with locomotive function. Briefly, each mouse was dropped in the same place of a
square arena (60-cm length) and video tracked for 10 min. The total distance of movement was
measured and quantified automatically.
Antibodies. Antibodies against L2hgdh (15707-1-AP; Proteintech), beta-actin (A00702; GenScript),
Hif-1 (610958; BD), eIF2 (9722; CST), and phospho-eIF2 (Ser51) (9721; CST) were used for Western
blotting. Gfap (MAB360; Millipore), Iba1 (019-441; Wako), Olig2 (AB9610; Millipore), Ng2 (AB53320;
Millipore), CC-1 (OP80-100UGCN; Millipore), collagen type IV (600-401-106; Rockland), Cd68 (14-0681-80;
eBioscience), nestin (MAB2736; R&D), Tbr2 (ab23345 Abcam), doublecortin (Dcx) (sc-241380; Santa Cruz),
and cleaved caspase-3 (Asp175) (5A1E) (CST 9664) were used for immunofluorescence or immunohis-
tochemistry.
Western blotting. Mouse tissues were lysed in radioimmunoprecipitation assay (RIPA) buffer sup-
plemented with a cocktail of protease inhibitors. Proteins were blotted by following standard protocols.
Tissue preparation and histology analysis. Frozen and paraffin-embedded sections were utilized
for histological analysis. Wild-type and KO littermates were perfused with PBS and then 4% PFA in PBS
at various time points. For frozen sections, brains were fixed in 4% PFA overnight at 4°C and transferred
sequentially to 15% and then 30% sucrose after the brain sank to the bottom. Brains were embedded and
frozen in OCT compound (Tissue-Tek), and 40-m serial sections were coronally prepared by frozen
microtome (CM1950; Leica). For paraffin-embedded sections, postfixed brains were sagittally or coronally
prepared at 4-m thickness. Slides from histologically comparable positions were picked for immuno-
histochemistry or immunofluorescence staining. To visualize myelinated fibers, frozen sections of brain
tissue were processed using Luxol fast blue staining (S3382; Sigma) or FluoroMyelin fluorescent myelin
staining (F34651; Thermo) according to standard protocols. For hematoxylin-eosin (HE) staining, paraffin-
embedded tissue sections (4 m) were used. To identify degenerating neurons, Fluoro-Jade C histofluo-
rescent staining was performed according to the manufacturer’s protocol (AG325-30MG; Millipore).
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IHC, IF, and confocal imaging. Immunocytochemistry (IHC) and immunofluorescence (IF) were
performed on paraffin sections and frozen sections, respectively. Visualization of primary antibodies was
performed by the avidin-biotin-horseradish peroxidase system for IHC and Alexa Fluor 488/647-
conjugated secondary antibodies (Invitrogen) for IF. The primary antibodies used in this study are listed
in “Antibodies,” above. Sections were visualized under a fluorescence laser scanning confocal microscope
(A1; Nikon).
Whole-body fat composition analysis. The fat composition of mice was measured nondestructively
by Bruker’s minispec whole-body composition analyzer by following the manufacturer’s instructions. The
method is based on time domain nuclear magnetic resonance (TD-NMR).
MRI analysis. We carried out T2-weighted MRI in vivo at 7.0 T using a Bruker BioSpin MRI GmbH
system according to standard procedures.
Metabolite extraction and GC-MS analysis. The GC-MS analysis was performed as previously
described (45). Standard curves of commercial L-2-HG and creatinine were used to quantify L-2-HG and
creatinine in the samples.
Measurement of GSSG and GSH levels. Oxidized glutathione (GSSG) and reduced glutathione (GSH)
levels were determined by using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Briefly,
tissues were homogenized by using 10-fold 80% (vol/vol) chilled methanol and then centrifuged at 12,000
rpm for 10 min at 4°C. The supernatant then was subjected to LC-MS/MS analysis using a Shimadzu LC system
coupled with a 4000-qtrap triple-quadrupole mass spectrometer (AB Sciex). A Phenomenex NH2 column
(inner diameter, 50 mm by 2.0 mm; particle size, 5 m) was used. The mass spectrometer was optimized and
set up in selected reaction monitoring (SRM) scan mode for monitoring the [M-H] of GSSG (m/z 611.6¡306.2)
and GSH (m/z 306.2¡142.8). Analyst software was used for analysis.
RNA isolation and qRT-PCR analysis. Total RNA was isolated from specific brain regions using
TransZol Up (TransGen) by following the manufacturer’s instructions. RNA was reverse transcribed with
random primer (N9) (TransGen) and proceeded to qRT-PCR with gene-specific primers by SYBR Premix
EX tag (TaKaRa). The relative expression abundance of specific genes was calculated by normalization to
the beta-actin control. Primer sequences can be provided upon request.
Quantitative analysis of 5mC and its derivatives. Quantification of genomic cytosine and its
derivatives was performed by LC-MS/MS as previously described (57).
Gene expression analysis. Next-generation sequencing was performed using standard methods.
Briefly, total RNA was extracted using TransZol Up (TransGen). Samples were quantified with an Agilent
2100 Bioanalyzer. Library preparation and RNA sequencing were conducted using TruSeq and a HiSeq
2500 platform (Illumina Inc., San Diego, CA) at WuXi AppTec (Shanghai, China).
For sequencing result analysis, paired-end reads were aligned to the mouse genome (mm9) after quality
filtering using Mapsplice, and we performed the quantitation with RSEM. Hierarchical clustering was per-
formed with the open-source application Cluster 3.0 and visualized with Java TreeView. The differential
expression analysis was carried out using DESeq2. We performed GO analysis with iPathwayGuide.
Histone methylation profiling. Histone methylation was quantified by MRM-based LC-MS/MS
(LC-MRM-MS), as described previously (23, 24). In short, the core histones were acid extracted from tissue
with 0.4 M H2SO4 and precipitated with trichloroacetic acid (TCA), followed by 2 washes with ice-cold
acetone. The histones were treated with N-hydroxysuccinimide-propionate and digested with trypsin.
Finally, the digested peptides were concentrated to dryness. Prior to LC-MRM-MS, a mixture of isotope-
labeled histone peptides was added as internal standards to the samples, and the histone peptide
concentration in the samples was calculated by the peak area ratio of histone peptides to internal
standard peptides.
Statistical methods. Results are presented as means  standard errors of the means (SEM) unless
otherwise specified. Statistical analysis was performed using two-tailed unpaired Student’s t test. P values
less than 0.05 were considered significant.
Accession number(s). The full data set has been deposited in the GEO public database under
accession number GSE89806.
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